Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Manning Anthony M.. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Manning Anthony M. har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:PTN / Palatin Technologies, Inc. | Director | 36 080 |
Chief Scientific Officer | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Manning Anthony M.. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Manning Anthony M. som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-07-16 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 12 000 | 36 080 | 49,83 | ||||
2023-06-22 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 10 000 | 36 693 | 37,46 | ||||
2022-06-24 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 73 000 | 693 667 | 11,76 | ||||
2021-06-24 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 77 000 | 461 666 | 20,02 | ||||
2021-06-24 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Stock Option (Right to Buy) |
A - Award | 128 000 | 128 000 | |||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −86 378 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −52 793 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 242 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −1 499 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 751 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −73 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −5 841 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 622 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −20 082 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −13 258 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −45 000 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −45 000 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −31 500 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −1 500 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −12 778 | 0 | −100,00 | ||||
2020-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −363 | 12 778 | −2,76 | 29,31 | −10 640 | 374 523 |
2020-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −40 | 13 141 | −0,30 | 29,34 | −1 174 | 385 557 |
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −347 | 13 181 | −2,57 | 32,36 | −11 229 | 426 537 |
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −750 | 1 500 | −33,33 | ||||
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 13 528 | 5,87 | ||||
2020-07-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 745 | 12 778 | −12,02 | 34,69 | −60 534 | 443 269 |
2020-07-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −194 | 14 523 | −1,32 | 34,67 | −6 726 | 503 512 |
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −33 125 | 52 793 | −38,55 | |||
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −49 538 | 14 717 | −77,10 | 33,91 | −1 679 834 | 499 053 |
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 561 | 64 255 | −2,37 | 33,95 | −52 996 | 2 181 457 |
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 33 125 | 65 816 | 101,33 | 12,76 | 422 675 | 839 812 |
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 500 | 31 500 | −10,00 | ||||
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 500 | 32 691 | 11,99 | ||||
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 811 | 29 191 | −18,92 | 35,10 | −239 066 | 1 024 604 |
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 15 000 | 45 000 | 50,00 | ||||
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 15 000 | 36 002 | 71,42 | ||||
2020-06-18 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Stock Option (right to buy) |
A - Award | 127 000 | 127 000 | |||||
2020-06-18 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 73 000 | 224 583 | 48,16 | ||||
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 756 | 21 002 | −24,34 | 30,15 | −203 693 | 633 210 |
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 15 000 | 30 000 | 100,00 | ||||
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 15 000 | 27 758 | 117,57 | ||||
2020-05-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −414 | 12 758 | −3,14 | 33,75 | −13 972 | 430 582 |
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −336 | 13 172 | −2,49 | 33,30 | −11 189 | 438 628 |
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −750 | 2 250 | −25,00 | ||||
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 13 508 | 5,88 | ||||
2020-04-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 886 | 12 758 | −12,88 | 30,55 | −57 617 | 389 757 |
2020-04-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 614 | 14 644 | −9,93 | 28,96 | −46 741 | 424 090 |
2020-04-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 500 | 35 000 | −9,09 | ||||
2020-04-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 500 | 16 258 | 27,43 | ||||
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 310 | 12 758 | −36,43 | 29,00 | −211 990 | 369 982 |
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 15 000 | 15 000 | |||||
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 15 000 | 20 068 | 295,97 | ||||
2020-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −16 459 | 5 068 | −76,46 | 32,56 | −535 905 | 165 014 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 541 | 22 316 | −27,68 | 30,03 | −256 486 | 670 149 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | 25 000 | 0 | −100,00 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −789 | 21 527 | −3,54 | 31,63 | −24 956 | 680 899 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 25 000 | 30 857 | 426,84 | ||||
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −112 | 5 857 | −1,88 | 32,23 | −3 610 | 188 771 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −224 | 5 969 | −3,62 | 31,50 | −7 056 | 188 024 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −750 | 3 000 | −20,00 | ||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 90 000 | 90 000 | |||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 45 000 | 45 000 | |||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 6 193 | 13,78 | ||||
2020-01-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −227 | 5 443 | −4,00 | 29,02 | −6 588 | 157 956 |
2020-01-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 038 | 5 670 | −26,44 | 29,01 | −59 122 | 164 487 |
2020-01-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 235 | 7 708 | −13,81 | 30,08 | −37 149 | 231 857 |
2020-01-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 500 | 38 500 | −8,33 | ||||
2020-01-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 500 | 8 943 | 64,30 | ||||
2020-01-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −7 500 | 16 500 | −31,25 | |||
2020-01-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −17 541 | 0 | −100,00 | |||
2020-01-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −4 073 | 0 | −100,00 | |||
2020-01-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −29 114 | 5 443 | −84,25 | 28,44 | −828 002 | 154 799 |
2020-01-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 500 | 34 557 | 27,72 | 18,85 | 141 375 | 651 399 |
2020-01-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 21 614 | 27 057 | 397,10 | 17,96 | 388 187 | 485 944 |
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −6 750 | 1 499 | −81,83 | |||
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −15 986 | 0 | −100,00 | |||
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 454 | 5 841 | −19,93 | |||
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −14 804 | 73 | −99,51 | |||
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −12 451 | 0 | −100,00 | |||
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −51 445 | 5 443 | −90,43 | 20,00 | −1 028 900 | 108 860 |
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 750 | 56 888 | 13,46 | 10,83 | 73 102 | 616 097 |
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 16 258 | 50 138 | 47,99 | 13,02 | 211 679 | 652 797 |
2019-12-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 28 437 | 33 880 | 522,45 | 12,58 | 357 737 | 426 210 |
2019-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −557 | 5 443 | −9,28 | 16,53 | −9 207 | 89 973 |
2019-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −62 | 6 000 | −1,02 | 16,52 | −1 024 | 99 120 |
2019-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −169 | 6 062 | −2,71 | 16,18 | −2 734 | 98 083 |
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −337 | 6 231 | −5,13 | 16,06 | −5 412 | 100 070 |
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −750 | 3 750 | −16,67 | ||||
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 6 568 | 12,89 | ||||
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 420 | 5 818 | −59,14 | 15,96 | −134 383 | 92 855 |
2019-10-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 365 | 14 238 | −30,89 | 13,83 | −88 028 | 196 912 |
2019-10-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −14 000 | 42 000 | −25,00 | ||||
2019-10-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 000 | 20 603 | 212,02 | ||||
2019-10-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −787 | 6 603 | −10,65 | 13,55 | −10 664 | 89 471 |
2019-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −114 | 7 390 | −1,52 | 11,64 | −1 327 | 86 020 |
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −221 | 7 509 | −2,86 | 11,82 | −2 612 | 88 756 |
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −750 | 4 500 | −14,29 | ||||
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 7 730 | 10,74 | ||||
2019-06-26 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Stock Option (right to buy) |
A - Award | 52 000 | 52 000 | |||||
2019-06-26 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 32 000 | 97 333 | 48,98 | ||||
2019-06-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −39 433 | 6 980 | −84,96 | 13,00 | −512 629 | 90 740 |
2019-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −114 | 46 413 | −0,25 | 14,00 | −1 596 | 649 782 |
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −224 | 46 527 | −0,48 | 13,68 | −3 064 | 636 489 |
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −750 | 5 250 | −12,50 | ||||
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 46 751 | 1,63 | ||||
2019-04-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −30 000 | 46 001 | −39,47 | ||||
2019-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 449 | 76 001 | −5,53 | 13,10 | −58 282 | 995 613 |
2019-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 717 | 80 450 | −8,75 | 12,70 | −98 006 | 1 021 715 |
2019-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −25 000 | 25 000 | −50,00 | ||||
2019-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 25 000 | 88 167 | 39,58 | ||||
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −133 | 63 167 | −0,21 | 12,77 | −1 698 | 806 643 |
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 106 000 | 106 000 | |||||
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −264 | 63 300 | −0,42 | 11,52 | −3 041 | 729 216 |
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −750 | 6 000 | −11,11 | ||||
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 63 564 | 1,19 | ||||
2018-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −113 | 62 814 | −0,18 | 13,15 | −1 486 | 826 004 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −750 | 6 750 | −10,00 | ||||
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −229 | 62 927 | −0,36 | 14,09 | −3 227 | 886 641 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 63 156 | 1,20 | ||||
2018-10-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 56 000 | 56 000 | |||||
2018-10-11 | 3 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
124 812 | ||||||||
2018-10-11 | 3 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
124 812 | ||||||||
2018-10-11 | 3 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
124 812 | ||||||||
2018-06-28 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Stock Option (right to buy) |
A - Award | 28 000 | 28 000 | |||||
2018-06-28 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 28 000 | 30 333 | 1 200,17 | ||||
2017-12-13 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2017-12-13 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 15 000 | 15 000 | |||||
2017-09-11 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Stock option (right to buy) |
A - Award | 54 000 | 54 000 | |||||
2017-09-11 |
|
4 | PTN |
PALATIN TECHNOLOGIES INC
Common Stock |
A - Award | 54 000 | 54 000 | |||||
2017-09-11 | 3 | PTN |
PALATIN TECHNOLOGIES INC
No Securities Beneficially Owned |
0 |